A carregar...

Cardioprotective effects of mineralocorticoid receptor antagonists at reperfusion

AIM: Pretreatment with mineralocorticoid receptor (MR) antagonists is reported to reduce myocardial infarct size from ischemia/reperfusion. Here, we tested whether the MR antagonists potassium canrenoate and eplerenone could protect in the more clinically relevant schedule of administration at the e...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Schmidt, Katharina, Tissier, Renaud, Ghaleh, Bijan, Drogies, Tim, Felix, Stephan B., Krieg, Thomas
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2010
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3063847/
https://ncbi.nlm.nih.gov/pubmed/20028693
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/eurheartj/ehp555
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!